© 2017, GENASSIST, Inc.
By Keith S. Wexler, MBA, Maternal Fetal Medicine, Prenatal Diagnosis and Biotech/Life Sciences Consultant, GENASSIST, Inc.
Paul Wexler, M.D., F.A.C.O.G., Medical Director, GENASSIST, Inc.
Clinical Professor, Department of OB/GYN, University of Colorado Health Sciences Center
Clinical Professor, Division of Genetics/Dept. of Pediatrics, Univ. of Colorado/The Children’s Hospital
Reiter’s Syndrome has a usual age of onset of approximately 20-50 years of age. It is more common in males than females.
Approximately 80% of individuals with the syndrome are HLA B27 compared with only 6-7% of the general population who are HLA B27.
Reiter’s Syndrome symptoms may be variable with the most frequent symptoms involved being:
- Joint and/or muscle pain
- Mucus membranes
- Inflammation of the genitourinary tract
Reiter’s Syndrome treatment may include:
- Non Steroidal Anti-Inflammatory Drugs (NSAID’s)
More severe symptoms may require stronger medications including:
- Enbrel (etanercept)
- Remicade (infliximab)
- Humira (adalimumab)
Diet modifications and various herbal approaches may offer relief to some patients.